Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business,based in New York. “We are ...

Evercore made slight adjustments to its estimates, reducing the Q4 2024 EPS forecast to $2.54 from $2.56 and the full-year 2025 estimate to $8.77 from $8.84, primarily due to softer international ...

On Friday, Evercore ISI reiterated its Outperform rating and $250.00 price target on Apple stock (current market cap: $3.43 trillion), highlighting the company's potential for an in-line quarter ...

Nvidia (NASDAQ:NVDA) was added to Evercore ISI's Tactical Outperform list on Monday as analysts turned bullish ahead of the company's fiscal fourth-quarter earnings report on February 26.

NEW YORK (AP) — NEW YORK (AP) — Evercore Inc. (EVR) on Wednesday reported net income of $140.4 million in its fourth quarter. The company, based in New York, said it had earnings of $3.30 per ...

Evercore ISI raised the firm’s price target on Astera Labs (ALAB) to $123 from $110 and keeps an Outperform rating on the shares. Shares were trading 4% lower despite December quarter revenue ...

Evercore ISI raised the firm’s price target on Goldman Sachs (GS) to $623 from $575 and keeps an Outperform rating on the shares. Equity markets sold off by about 2% in December in “a post ...

Good morning, and welcome to the Evercore Fourth Quarter 2024 and Full-Year Earnings Conference Call. Today's call is scheduled to last about 1 hour, including remarks by Evercore management and ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $515.00. The company’s shares ...